Geneos Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.23M Sell
17,815
-28,558
-62% -$1.97M 0.03% 480
2025
Q1
$3.22M Buy
46,373
+27,054
+140% +$1.88M 0.05% 378
2024
Q4
$1.66M Sell
19,319
-2,483
-11% -$214K 0.06% 321
2024
Q3
$2.6M Buy
21,802
+5,714
+36% +$680K 0.1% 240
2024
Q2
$2.3M Sell
16,088
-329
-2% -$47K 0.1% 229
2024
Q1
$2.11M Buy
16,417
+1,641
+11% +$211K 0.1% 242
2023
Q4
$1.53M Buy
14,776
+750
+5% +$77.6K 0.08% 264
2023
Q3
$1.28M Buy
14,026
+424
+3% +$38.6K 0.07% 276
2023
Q2
$1.1M Buy
13,602
+1,758
+15% +$142K 0.06% 301
2023
Q1
$942K Buy
11,844
+3,238
+38% +$258K 0.06% 301
2022
Q4
$582K Buy
8,606
+5,520
+179% +$374K 0.04% 387
2022
Q3
$153K Buy
3,086
+442
+17% +$21.9K 0.01% 678
2022
Q2
$147K Sell
2,644
-66
-2% -$3.67K 0.01% 861
2022
Q1
$150K Buy
2,710
+88
+3% +$4.87K 0.01% 927
2021
Q4
$146K Buy
2,622
+816
+45% +$45.4K 0.01% 1016
2021
Q3
$86K Hold
1,806
﹤0.01% 1230
2021
Q2
$76K Sell
1,806
-290
-14% -$12.2K ﹤0.01% 1282
2021
Q1
$77K Hold
2,096
﹤0.01% 1409
2020
Q4
$61K Sell
2,096
-666
-24% -$19.4K ﹤0.01% 1357
2020
Q3
$95K Buy
2,762
+200
+8% +$6.88K ﹤0.01% 961
2020
Q2
$84K Buy
2,562
+200
+8% +$6.56K ﹤0.01% 997
2020
Q1
$66K Sell
2,362
-1,930
-45% -$53.9K ﹤0.01% 1002
2019
Q4
$125K Sell
4,292
-894
-17% -$26K 0.01% 867
2019
Q3
$133K Hold
5,186
0.01% 795
2019
Q2
$132K Sell
5,186
-1,200
-19% -$30.5K 0.01% 811
2019
Q1
$167K Buy
6,386
+94
+1% +$2.46K 0.01% 706
2018
Q4
$144K Sell
6,292
-378
-6% -$8.65K 0.01% 712
2018
Q3
$157K Sell
6,670
-3,620
-35% -$85.2K 0.01% 732
2018
Q2
$237K Buy
10,290
+450
+5% +$10.4K 0.02% 525
2018
Q1
$242K Buy
9,840
+670
+7% +$16.5K 0.02% 485
2017
Q4
$246K Sell
9,170
-770
-8% -$20.7K 0.02% 480
2017
Q3
$239K Hold
9,940
0.02% 463
2017
Q2
$213K Hold
9,940
0.02% 483
2017
Q1
$170K Buy
9,940
+720
+8% +$12.3K 0.02% 522
2016
Q4
$165K Buy
9,220
+1,282
+16% +$22.9K 0.02% 502
2016
Q3
$165K Buy
7,938
+178
+2% +$3.7K 0.02% 482
2016
Q2
$210K Hold
7,760
0.03% 422
2016
Q1
$213K Buy
+7,760
New +$213K 0.03% 423